Arrowstreet Capital’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49,545
Closed -$1.21M – 2120
2026
Q2
$1.21M Sell
49,545
-38,336
-44% -$693K ﹤0.01% 1616
2026
Q1
$1.54M Buy
+87,881
New +$1.69M ﹤0.01% 1456

Other funds holding BIOA

Arrowstreet Capital's BIOA Position: Q3 2026 in Review

Arrowstreet Capital sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 49,545 shares — an estimated $1.21M sold.

Arrowstreet Capital first reported a position in BIOA in Q1 2026 and held it in 2 quarters. The position peaked at $1.54M in Q1 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Arrowstreet Capital reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 49,545 BioAge Labs shares in Q3 2026, an estimated $1.21M.
  • Arrowstreet Capital first reported a position in BioAge Labs in Q1 2026 and held it in 2 quarters.
  • Arrowstreet Capital's BioAge Labs position peaked at $1.54M in Q1 2026.
  • 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.